Growth Metrics

Neuroone Medical Technologies (NMTC) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Neuroone Medical Technologies (NMTC) over the last 5 years, with Q4 2025 value amounting to -$40754.0.

  • Neuroone Medical Technologies' Cash from Investing Activities fell 6691.51% to -$40754.0 in Q4 2025 from the same period last year, while for Dec 2025 it was -$98080.0, marking a year-over-year increase of 874.75%. This contributed to the annual value of -$81742.0 for FY2025, which is 3199.33% up from last year.
  • Per Neuroone Medical Technologies' latest filing, its Cash from Investing Activities stood at -$40754.0 for Q4 2025, which was down 6691.51% from -$10607.0 recorded in Q3 2025.
  • Neuroone Medical Technologies' Cash from Investing Activities' 5-year high stood at $1.8 million during Q1 2023, with a 5-year trough of -$3.0 million in Q3 2022.
  • In the last 5 years, Neuroone Medical Technologies' Cash from Investing Activities had a median value of -$33234.5 in 2021 and averaged -$45228.6.
  • As far as peak fluctuations go, Neuroone Medical Technologies' Cash from Investing Activities crashed by 854656.07% in 2022, and later surged by 205491.38% in 2023.
  • Over the past 5 years, Neuroone Medical Technologies' Cash from Investing Activities (Quarter) stood at -$61491.0 in 2021, then surged by 124.51% to $15069.0 in 2022, then crashed by 346.41% to -$37131.0 in 2023, then soared by 34.24% to -$24416.0 in 2024, then crashed by 66.92% to -$40754.0 in 2025.
  • Its Cash from Investing Activities was -$40754.0 in Q4 2025, compared to -$10607.0 in Q3 2025 and -$43548.0 in Q2 2025.